Drugs.com - Pharma Industry News

De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome

WEDNESDAY, Feb. 19, 2025 -- For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower bleeding risk...

Feb 19, 2025 - 18:52
 0
De-Escalating DAPT to Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome
WEDNESDAY, Feb. 19, 2025 -- For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is associated with lower bleeding risk...
Read More

Tags:

Previous Article

Calls to Poison Centers on the Rise for Pediatric Exposures to Caffeine Energy P...

Next Article

Traumatic Experiences Associated With Endometriosis

Related Posts

Study Identifies Some Modifiable Risk Factors for Ovarian Cancer

Study Identifies Some Modifiable Risk Factors for Ovari...

Feb 11, 2025  0

Acute Toxicity Following Prostate Radiotherapy Linked to Late Toxicity

Acute Toxicity Following Prostate Radiotherapy Linked t...

Feb 12, 2025  0

Four Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALS

Four Immunoassays for Neurofilament Light Chain Show Co...

Feb 27, 2025  0